Novavax hopes to file for US vaccine approval in 2nd quarter of 2021
Greenhouse gas emissions associated with dietary guidelines vary between countries
2 March 2021New study gives the most detailed look yet at the neuroscience of placebo effects
2 March 2021Novavax hopes to file for US vaccine approval in 2nd quarter of 2021
US biotech company Novavax said Monday it hopes to file for British approval of its COVID-19 vaccine at the start of the second quarter of 2021, and to do the same soon after in the United States.
